Long-Acting Cabotegravir, Rilpivirine Noninferior in HIV-1
Studies demonstrate noninferiority to standard oral therapy, dolutegravir-abacavir-lamivudine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Studies demonstrate noninferiority to standard oral therapy, dolutegravir-abacavir-lamivudine
Only registered members have full access to PracticeUpdate content.